Jun
10
Originally published on June 2, 2021, by Sasha Jones for Bloomberg News.
The future of the office sector remains largely uncertain at this point post-pandemic, but there’s one segment that continues to see huge gains.
Investors have spent more than $10 billion on buying life sciences buildings this year, Bloomberg News reported, citing data from Real Capital Analytics. That’s about 4 percent of all global commercial real estate transactions through May, twice what was recorded at the same time last year.
And those numbers don’t even include new life-science developments, such as Boston’s massive Fenway Center, which broke ground in 2017.
Read More
Share this post: